Global Methicillin-Resistant Staphylococcus Aureus drugs Market 2016-2018 & 2024 - ResearchAndMarkets.com

DUBLIN--()--The "Methicillin-Resistant Staphylococcus Aureus drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.

The report predicts the global methicillin-resistant staphylococcus aureus drugs market to grow with a CAGR of 2.5% over the forecast period of 2018-2024.

The report on global methicillin-resistant staphylococcus aureus drugs market provides qualitative and quantitative analysis for the period of 2016 to 2024.

The report on methicillin-resistant staphylococcus aureus drugs market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global methicillin-resistant staphylococcus aureus drugs market over the period of 2016 to 2024. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global methicillin-resistant staphylococcus aureus drugs market over the period of 2016 to 2024. Further, the Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Segment Covered

The global methicillin-resistant staphylococcus aureus drugs market is segmented on the basis of drug class, MOA and drug origin.

Global Methicillin-resistant Staphylococcus Aureus drugs Market by Drug Class

  • Cephalosporin
  • Lipopeptides
  • Lipoglycopeptide
  • Folate Antagonist
  • Tetracycline
  • Oxazolidinone

Global Methicillin-resistant Staphylococcus Aureus drugs Market by MOA

  • Bactericidal Drugs
  • Bacteriostatic

Global Methicillin-resistant Staphylococcus Aureus drugs Market by Drug Origin

  • Synthetic Drugs
  • Semisynthetic

Company Profiles

  • Theravance Biopharma
  • Basilea Pharmaceutica
  • Pfizer
  • Debiopharm Group
  • Merck
  • Allergan
  • Melinta Therapeutics
  • AmpliPhi Biosciences Corporation
  • KYORIN Pharmaceutical Co. Ltd.
  • Baxter International

For more information about this report visit https://www.researchandmarkets.com/research/r5mbmm/global?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Antibiotics

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Antibiotics